Patients usually remain ambulant, although some of them need mobility aids
Tibial muscular dystrophy(TMD) (also known as Udd myopathy) is a rare hereditary disorder, which is caused by a mutation in a gene TTN.[2] TMD usually begins at the age of 35-55 years and the disease progresses slowly.[3] The disorder causes weakness and atrophy of tibialis anterior, extensor digitorum longus, extensor hallucis longus.[3]
TMD is most common in Finland, which is estimated to be 15:100,000 individuals due to founder effect.[4]
Symptoms
In TMD, patients experience problems with dorsiflexion, which causes problems with lifting foot.
Usually patients first experience weakness of dorsiflexion of feet and incapability to walk on the heels, because of atrophy of anterior compartment of leg . Later (usually after 10 to 20 years), patients experience weakness in long toe extensors, which causes foot drop.[4]
The diagnosis of TMD is suspected by its typical findings, and confirmed by finding monoallelic mutations in the last exon of TTN gene by genetic testing.[4] Serum creatine kinase values are usually normal or slightly raised, also in MRI/CT of the leg, shows fatty degeneration of tibialis anterior.[6]
Cause
This illustration shows titin structure and its last exons, where TMD mutations are occurring, table shows mutations associated with TMD.
TMD is caused by a specific mutations in a gene TTN, which encodes protein titin.[10] TMD associated mutations are located on the last exon Mex6.[10] Finnish patients usually have a unique 11-bp indel mutation, which changes 4 amino acid residues.[11][4]
TMD cases have been documented in other countries, including France, Italy, and Belgium, with their own unique mutations.[7][8][9]
Pathophysiology
In the Finnish variant of TMD mutations, there is an abnormal cleavage of C-terminal part of titin by proteases, which causes dysrgulation of another protease calpain-3.[12]
Also, there is an activation of ER stress, and its activation is insufficient to correct abnormalities of protein, which cause degenerative processes in TMD muscle fibres, in addition there are rimmed vacuoles with accumulation of VCP inside.[13] This causes distortion of pathways, that are related to controlling turnover and degradation (which includes autophagy), leading to muscle fibre loss.[13]
Treatment
Orthotics can be used in TMD
TMD doesn't have a cure, but managing of symptoms is possible.[4] Management includes use of orthotic device, and in severe cases, tibial posterior tendon transposition, in addition, some of the patients need mobility aid.[4]
History
This disorder was first described by Bjarne Udd (and consequently named after him) and by his colleagues in 1991.[14]
12Pollazzon, Marzia; Suominen, Tiina; Penttilä, Sini; Malandrini, Alessandro; Carluccio, Maria Alessandra; Mondelli, Mauro; Marozza, Annabella; Federico, Antonio; Renieri, Alessandra; Hackman, Peter; Dotti, Maria Teresa; Udd, Bjarne (2009-11-13). "The first Italian family with tibial muscular dystrophy caused by a novel titin mutation". Journal of Neurology. 257 (4): 575–579. doi:10.1007/s00415-009-5372-3. ISSN1432-1459. PMID19911250.
12Van den Bergh, Peter Y. K.; Bouquiaux, Olivier; Verellen, Christine; Marchand, Sylvie; Richard, Isabelle; Hackman, P.; Udd, Bjarne (2003-07-25). "Tibial muscular dystrophy in a Belgian family". Annals of Neurology. 54 (2): 248–251. doi:10.1002/ana.10647. ISSN0364-5134. PMID12891679.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.